Details of the Drug

General Information of Drug (ID: DMT6IYM)

• Drug Name: MGTA-456

Indication

Disease Entry	ICD 11	Status	REF
Metabolic disorder	5C50-5D2Z	Phase 2	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: D14SKB

References

• [1] ClinicalTrials.gov (NCT03406962) MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT). U.S. National Institutes of Health.